Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun;26(6):1927-1931.
doi: 10.1007/s00520-017-4023-y. Epub 2017 Dec 28.

Transfusion practices at end of life for hematopoietic stem cell transplant patients

Winnie S Wang  1 , Joseph D Ma  2 , Sandahl H Nelson  3 , Carolyn Revta  4 , Gary T Buckholz  4 , Carolyn Mulroney  5 , Eric J Roeland  6
Affiliations

Transfusion practices at end of life for hematopoietic stem cell transplant patients

Winnie S Wang et al. Support Care Cancer. 2018 Jun.

Abstract

Purpose: Limited data exist regarding transfusion practices at end of life (EOL) for hematopoietic stem cell transplant (HSCT) patients. The purpose of this study was to examine red blood cell (RBC) and platelet transfusion practices in HSCT patients who enrolled or did not enroll in hospice.

Methods: This was a single-center, retrospective chart review in deceased HSCT patients. The primary objective was to determine the mean difference between the last transfusion and death in HSCT patients (n = 116) who enrolled or did not enroll in hospice.

Results: Sixteen (14%) and 100 (86%) patients were enrolled in hospice and not enrolled in hospice, respectively. Hospice patients observed a larger mean difference between death and last transfusion (45.9 ± 66.7 vs. 14.6 ± 48.1 days, p < 0.0001). A higher amount of platelet, but not RBC, transfusions occurred in patients not enrolled in hospice (p = 0.04). The last transfusion that occurred more than 96 h before death was observed in 12 (75%) and 22 (22%) in hospice and non-hospice patients, respectively. For HSCT patients not enrolled in hospice, 17 patients received a transfusion on the same day of death and 31 patients received the last transfusion 24 h before death.

Conclusions: Blood transfusion practices differed in HSCT patients enrolled and not enrolled in hospice. For most patients not enrolled in hospice, the last transfusion occurred 24 h before death. Future efforts should explore if limited access to blood products is a barrier to hospice enrollment for HSCT patients.

Keywords: Blood transfusion; End of life; Hematologic malignancies; Hospice; Stem cell transplantation.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST The Authors declare no conflict of interest related to this article.

References

    1. Gleeson C, Spencer D. Blood transfusion and its benefits in palliative care. Palliat Med. 1995;9(4):307–313. - PubMed
    1. LeBlanc TW. Palliative care and hematologic malignancies: old dog, new tricks? Journal of oncology practice/American Society of Clinical Oncology. 2014;10(6):e404–407. - PubMed
    1. Mannis GN, McNey LM, Gupta NK, Gross DM. The transfusion tether: Bridging the gap between end-stage hematologic malignancies and optimal end-of-life care. American journal of hematology. 2016;91(4):364–365. - PubMed
    1. Mercadante S, Ferrera P, Villari P, David F, Giarratano A, Riina S. Effects of red blood cell transfusion on anemia-related symptoms in patients with cancer. J Palliat Med. 2009;12(1):60–63. - PubMed
    1. To TH, To LB, Currow DC. Can We Detect Transfusion Benefits in Palliative Care Patients? J Palliat Med. 2016;19(10):1110–1113. - PubMed

MeSH terms

LinkOut - more resources